Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.46M Sell
2,745
-254
-8% -$404K 2.42% 18
2026
Q1
$3.96M Sell
2,999
-3
-0.1% -$4.11K 1.71% 29
2025
Q4
$2.96M Sell
3,002
-55
-2% -$57.4K 1.46% 30
2025
Q3
$2.74M Sell
3,057
-9
-0.3% -$7.08K 1.36% 29
2025
Q2
$2.28M Sell
3,066
-52
-2% -$37.3K 1.19% 29
2025
Q1
$1.95M Buy
+3,118
New +$2.27M 0.99% 30

Other funds holding ASML

Baugh & Associates's ASML Position: Q2 2026 in Review

Baugh & Associates reduced its ASML (ASML) stake by 8.5% in Q2 2026, selling an estimated $404K and leaving 2,745 shares worth $5.46M. The position accounts for 2.42% of the portfolio, ranked #18.

Baugh & Associates first reported a position in ASML in Q1 2025 and has held it in 6 quarters since. 1,116 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Baugh & Associates held 2,745 shares of ASML worth $5.46M as of Q2 2026.
  • Baugh & Associates sold 254 ASML shares in Q2 2026, an estimated $404K.
  • ASML made up 2.42% of Baugh & Associates's portfolio in Q2 2026, its #18 holding.
  • Baugh & Associates first reported a position in ASML in Q1 2025 and has held it in 6 quarters since.
  • 1,116 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Baugh & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.